Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioLase Technology, Inc. (BLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Narotham Reddy who wrote (243)	12/10/1997 4:45:00 PM
From: Clayleas	Read Replies (1) \| Respond to of 706

Wednesday December 10, 8:33 am Eastern Time Company Press Release BIOLASE Technology, Inc. Announces $2.5 Million Credit Facility SAN CLEMENTE, Calif.--(BW HealthWire)--Dec. 10, 1997--BIOLASE Technology, Inc. (NASDAQ:BLTI - news), a provider of laser-based advanced cosmetic, aesthetic, dental and surgical products, today announced that the company had obtained a $2.5 million line of credit to be utilized to acquire and manufacture inventory. The credit facility has been obtained from the New York branch of Banca della Svizzera Italiana, a subsidiary of Swiss Bank Corporation, and is for the term of one year with the two six (6) month renewal options. According to Donald A. La Point, president and chief executive officer of BIOLASE, ''This line of credit is very significant because it provides the financial resources required to meet the strong demand that we are experiencing internationally and domestically for our Hydro-Kinetic(TM) tissue cutting system, the Millennium(TM).'' BIOLASE Technology, Inc. manufactures and markets advanced cosmetic, aesthetic, dental and surgical products, including laser systems, Hydro-Kinetic(TM) surgical cutting systems, and develops specialized biomaterials for dentistry and other medical specialties. The company's products incorporate patented and patent-pending technologies that permit achievement of unique results. The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time-to-time in the company's filings with the Securities and Exchange Commission, including the reports on Forms 10-KSB and 10Q. Actual results may differ materially from those projected. These forward looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements. -------------------------------------------------------------------------------- Contact: BIOLASE Technology, Inc. Donald A. La Point, 714/361-1200 or Pacific Consulting Group Scott Liolios, 714/574-3860 --------------------------------------------------------------------------------